Results 321 to 330 of about 2,947,895 (397)

RNA‐Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications

MedComm – Oncology, Volume 5, Issue 1, March 2026.
Ferroptosis critically influences cancer cell fate and represents a promising therapeutic strategy. Emerging evidence identifies RNA‐binding proteins (RBPs) as key post‐transcriptional regulators of ferroptosis. The figure summarizes ferroptosis‐related RBPs across cancers: blue RBPs act as tumor suppressors by promoting ferroptosis, whereas red RBPs ...
Linlin Chang, Bin Lu, Haotian Shang, Wanjing Ding, Chunhua Wei, Xiaotian Qi, Pengxing He   +6 more
wiley   +1 more source

Social Interaction in Adolescent Rats with Neonatal Ethanol Exposure: Impact of Sex and CE-123, a Selective Dopamine Reuptake Inhibitor. [PDF]

Int J Mol Sci
Socha J, Grochecki P, Smaga I, Jastrzębska J, Wronikowska-Denysiuk O, Marszalek-Grabska M, Slowik T, Kotlinski R, Filip M, Lubec G, Kotlinska JH.   +10 more
europepmc   +1 more source

Cardiotropic Gene Therapy for Heart Failure: Translational Lessons From AB‐1002

MedComm – Future Medicine, Volume 5, Issue 1, March 2026.
Nghia Phu Nguyen, Phillip Tran
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Selective Serotonin Reuptake Inhibitor Exposure

Topics in Companion Animal Medicine, 2013
Many antidepressants inhibit serotonin or norepinephrine reuptake or both to achieve their clinical effect. The selective serotonin reuptake inhibitor class of antidepressants (SSRIs) includes citalopram, escitalopram (active enantiomer of citalopram), fluoxetine, fluvoxamine, paroxetine, and sertraline.
Kevin T, Fitzgerald, Alvin C, Bronstein
openaire   +3 more sources

Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal

British Journal of Psychiatry, 2020
Summary Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term ‘discontinuation syndrome’ are not supported by evidence.
Ivana Massabki, Elia Abi-Jaoude
semanticscholar   +1 more source

Serotonin Reuptake Inhibitor Withdrawal

Journal of Clinical Psychopharmacology, 1996
We studied reported withdrawal symptoms in a retrospective chart review of 352 patients treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor clomipramine or with one of the selective serotonin reuptake inhibitors (SSRIs), fluoxetine, fluvoxamine, paroxetine, or sertraline.
N J, Coupland, C J, Bell, J P, Potokar
openaire   +2 more sources